Sorrento ousts CFO as long-running Covid-19 drama continues
Accelerate Diagnostics Pops 10% On US Emergency Use Nod For Covid-19 Testing
New Study May Provide Insights Into Novavax’s COVID-19 Vaccine; Top Analyst Weighs In
Yale’s COVID-19 saliva test used in NBA gets FDA OK for emergency use
Baxter Gets FDA Emergency Use Nod For Regiocit During Covid-19 Pandemic
Once We Have An Approved COVID-19 Vaccine, Then What?
Rapid screening tests that prioritize speed over accuracy could be key to ending the coronavirus pandemic
Quidel’s Lyra Covid-19 Test Gets Nod For Sale In Canada; Shares Rise 6%
Gilead Submits New Drug Application With FDA For Remdesivir
Pfizer signs deal with Gilead to manufacture COVID-19 antiviral remdesivir
Australia Approves Co-Diagnostics' Covid-19 Test; Stock Falls On Profit-Taking
Abiomed’s Impella Scores Emergency FDA Nod For Covid-19 Patients
CRISPR Startups Give Genome Editing Several New Twists
Pooling strategy in the wake of the COVID-19 pandemic: A solution for mass population screening of SARS-CoV-2
Quest Gets FDA Nod For Faster Covid-19 Testing; Analyst Flips To Buy Call
Upcoming Phase 2 COVID-19 Trial Marks Key Milestone for Sorrento (SRNE); Analyst Says ‘Buy’
Pfizer, BioNTech Surge On US Gov Deal For 600M Covid-19 Vaccine Doses
Quest Scores US Nod For Covid-19 Test Pooling; Speeding Up Response Times
Experts urge transparency, advisory committee review for Covid-19 vaccines
Becton, Dickinson Score Fed Contract For Covid-19 Rapid Test Systems
Equillium (EQ) Stock Price Target Gets a Big Boost; Here's What You Need to Know
ElectroCore Pops 160% On FDA Nod For Covid-19 Asthma Device
Could pressure for COVID-19 drugs lead the FDA to lower its standards?
Gilead Reveals Additional Data On Covid-19 Treatment Remdesivir
HHS allocates Gilead’s Covid-19 drug remdesivir to four hardest hit states
GenMark Diagnostics (GNMK) Stock Is a Winner, But How Much Higher Can It Go?
Can This Coronavirus Stock Soar 230%? 5-Star Analyst Thinks So
A new study points to $6.5B in public support building the scientific foundation of Gilead's remdesivir. Should that be reflected in the price?
Novavax Secures $1.6B in Funding for COVID-19 Vaccine Efforts
Novavax Wins $1.6B in “Warp Speed” Funding; Plans First 100M Doses of COVID-19 Vaccine